Eric Lev is a seasoned professional in the healthcare investment sector, currently serving as a Board Member at BIOLOGOS and P95, and as a General Partner at Ampersand Capital Partners since February 2013, where the focus is on growth-oriented healthcare investments. Lev's extensive board experience includes positions at iuvo BioScience, Biosynth, ALPCO, and Resolian, among others, contributing to strategic guidance in various organizations. An alumnus of The University of Chicago Booth School of Business with an MBA and Northwestern University with a BA in Economics, Eric Lev possesses a strong educational foundation that supports a robust career in the industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices